PIK3C2B inhibition improves function and prolongs survival in myotubular myopathy animal models.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of Clinical Investigation

• Publication date

  2016-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1172/JCI86841PMID 27548528PMCID PMC5004942
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A phosphoinositide conversion mechanism for exit from endosomes

  2016cited by this paper
• Drugging PI3K in cancer: refining targets and therapeutic strategies

  2015cited by this paper
• Inactivation of the Class II PI3K-C2β Potentiates Insulin Signaling and Sensitivity

  2015cited by this paper
• Gene replacement rescues severe muscle pathology and prolongs survival in myotubularin-deficient mice and dogs.

  2015cited by this paper
• Phosphatidylinositol 3-kinase, class 2 beta (PI3KC2β) isoform contributes to neuroblastoma tumorigenesis.

  2015cited by this paper
• Gene Therapy Prolongs Survival and Restores Function in Murine and Canine Models of Myotubular Myopathy

  2014cited by this paper
• Characterization of VPS34-IN1, a selective inhibitor of Vps34, reveals that the phosphatidylinositol 3-phosphate-binding SGK3 protein kinase is a downstream target of class III phosphoinositide 3-kinase

  2014cited by this paper
• Loss of Fig4 in both Schwann cells and motor neurons contributes to CMT4J neuropathy

  2014cited by this paper
• Conditional knockout of pik3c3 causes a murine muscular dystrophy.

  2014cited by this paper
• Regulation of Mammalian Autophagy by Class II and III PI 3-Kinases through PI3P Synthesis

  2013cited by this paper
• Photochemical activation of TRPA1 channels in neurons and animals

  2013cited by this paper
• A class II phosphoinositide 3-kinase plays an indispensable role in hepatitis C virus replication.

  2013cited by this paper
• Myotubularin and PtdIns3P remodel the sarcoplasmic reticulum in muscle in vivo

  2013cited by this paper
• Murine Fig4 is dispensable for muscle development but required for muscle function

  2013cited by this paper
• De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes

  2012influential reference
• Two PI 3-Kinases and One PI 3-Phosphatase Together Establish the Cyclic Waves of Phagosomal PtdIns(3)P Critical for the Degradation of Apoptotic Cells

  2012cited by this paper
• Modeling the human MTM1 p.R69C mutation in murine Mtm1 results in exon 4 skipping and a less severe myotubular myopathy phenotype.

  2012cited by this paper
• Mammalian PIK3C3/VPS34

  2012cited by this paper
• Myotubularin phosphoinositide phosphatases: cellular functions and disease pathophysiology.

  2012cited by this paper
• Defective Autophagy and mTORC1 Signaling in Myotubularin Null Mice

  2012cited by this paper
• Pik3c3 deletion in pyramidal neurons results in loss of synapses, extensive gliosis and progressive neurodegeneration.

  2011cited by this paper
• T-tubule biogenesis and triad formation in skeletal muscle and implication in human diseases

  2011cited by this paper
• Genetic Interaction between MTMR2 and FIG4 Phospholipid Phosphatases Involved in Charcot-Marie-Tooth Neuropathies

  2011cited by this paper
• Myotubularin Regulates Akt-dependent Survival Signaling via Phosphatidylinositol 3-Phosphate*

  2011cited by this paper
• Comprehensive analysis of kinase inhibitor selectivity

  2011cited by this paper
• Zebrafish MTMR14 is required for excitation-contraction coupling, developmental motor function and the regulation of autophagy.

  2010cited by this paper
• Drosophila Mtm and class II PI3K coregulate a PI(3)P pool with cortical and endolysosomal functions

  2010cited by this paper
• Deleterious variants of FIG4, a phosphoinositide phosphatase, in patients with ALS.

  2009influential reference
• T-tubule disorganization and defective excitation-contraction coupling in muscle fibers lacking myotubularin lipid phosphatase

  2009cited by this paper
• Loss of Myotubularin Function Results in T-Tubule Disorganization in Zebrafish and Human Myotubular Myopathy

  2009cited by this paper
• Phosphoinositide‐metabolizing enzymes at the interface between membrane traffic and cell signalling

  2007cited by this paper
• Phosphoinositides in cell regulation and membrane dynamics

  2006cited by this paper
• Phosphoinositides in cell regulation and membrane dynamics

  2006cited by this paper
• A pharmacological map of the PI3-K family defines a role for p110alpha in insulin signaling.

  2006cited by this paper
• A Pharmacological Map of the PI3-K Family Defines a Role for p110α in Insulin Signaling

  2006cited by this paper
• The Class II Phosphoinositide 3-Kinase C2β Is Not Essential for Epidermal Differentiation

  2005cited by this paper
• Impaired PtdIns(4,5)P2 synthesis in nerve terminals produces defects in synaptic vesicle trafficking

  2004cited by this paper
• Mutations in MTMR13, a new pseudophosphatase homologue of MTMR2 and Sbf1, in two families with an autosomal recessive demyelinating form of Charcot-Marie-Tooth disease associated with early-onset glaucoma.

  2003cited by this paper
• The lipid phosphatase myotubularin is essential for skeletal muscle maintenance but not for myogenesis in mice

  2002cited by this paper
• Genotype-phenotype correlations in X-linked myotubular myopathy.

  2002cited by this paper
• A gene mutated in X–linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast

  1996influential reference

• Lack of myotubularin phosphatase activity is the main cause of X-linked myotubular myopathy

  2025influential citation
• Decoding class II PI3K signaling: From membrane identity to human disease.

  2025cites this paper
• Integrative Approaches to Myopathies and Muscular Dystrophies: Molecular Mechanisms, Diagnostics, and Future Therapies

  2025cites this paper
• Aberrant lysosomal dynamics disrupt myogenesis via mTORC1 signalling in X-linked myotubular myopathy.

  2025cites this paper
• microRNA-133a as an indicator of disease progression and treatment response in X-linked myotubular myopathy

  2025cites this paper
• X-linked myotubular myopathy: an untreated treatable disease

  2025influential citation
• Characterization of a novel zebrafish model of MTMR5-associated Charcot-Marie-Tooth disease type 4B3

  2025cites this paper
• PI3KC2β depletion rescues endosomal trafficking defects in Mtm1 knockout skeletal muscle cells

  2025cites this paper
• Phosphoinositide switches in cell physiology - From molecular mechanisms to disease

  2024cites this paper
• Standardization of zebrafish drug testing parameters for muscle diseases

  2024cites this paper
• Potential compensatory mechanisms preserving cardiac function in myotubular myopathy

  2024cites this paper
• Dietary pro-oxidant therapy by a vitamin K precursor targets PI 3-kinase VPS34 function

  2024cites this paper
• A pro-oxidant suppresses unrelated diseases

  2024cites this paper
• Aligning with the 3Rs: alternative models for research into muscle development and inherited myopathies

  2024cites this paper
• A healthcare claims analysis to identify and characterize patients with suspected X-Linked Myotubular Myopathy (XLMTM) in the Brazilian Healthcare System

  2024cites this paper
• [The PI3KC2β kinase as a therapeutic target for myotubular myopathy].

  2024cites this paper
• Statistical detecting of genes associated with PIK3C2B on lung disease

  2023cites this paper
• Inactivating the lipid kinase activity of PI3KC2β is sufficient to rescue myotubular myopathy in mice

  2023cites this paper
• Congenital myopathies.

  2023cites this paper
• [PI3KC2β: A promising therapeutic target in myotubular myopathy].

  2023cites this paper
• Loss of Mtm1 causes cholestatic liver disease in a model of X-linked myotubular myopathy

  2023cites this paper
• Real-world analysis of healthcare resource utilization by patients with X-linked myotubular myopathy (XLMTM) in the United States

  2023cites this paper
• Integration of Selection Signatures and Protein Interactions Reveals NR6A1, PAPPA2, and PIK3C2B as the Promising Candidate Genes Underlying the Characteristics of Licha Black Pig

  2023cites this paper
• INCEPTUS Natural History, Run-in Study for Gene Replacement Clinical Trial in X-Linked Myotubular Myopathy

  2022cites this paper
• Characterization of a novel zebrafish model of SPEG-related centronuclear myopathy

  2022cites this paper
• Therapeutic approaches in different congenital myopathies.

  2022cites this paper
• Beyond PI3Ks: targeting phosphoinositide kinases in disease

  2022cites this paper
• Antagonistic control of active surface integrins by myotubularin and phosphatidylinositol 3-kinase C2β in a myotubular myopathy model

  2022cites this paper
• X-linked myotubular myopathy is associated with epigenetic alterations and is ameliorated by HDAC inhibition

  2022influential citation
• Defective lipid signalling caused by mutations in PIK3C2B underlies focal epilepsy

  2022cites this paper
• Dynamin-2 reduction rescues the skeletal myopathy of a SPEG-deficient mouse model

  2022cites this paper
• Clinical Characteristics and Neurologic Outcomes of X-Linked Myotubular Myopathy

  2022cites this paper
• Variants in ASPH cause exertional heat illness and are associated with malignant hyperthermia susceptibility

  2022cites this paper
• Phosphoinositides as membrane organizers

  2022cites this paper
• The molecular mechanisms mediating class II PI 3‐kinase function in cell physiology

  2021cites this paper
• X-linked myotubular myopathy.

  2021cites this paper
• Class II phosphatidylinositol 3-kinase isoforms in vesicular trafficking

  2021cites this paper
• Respiratory care in myotubular myopathy

  2021cites this paper
• A robust method for performing 1H-NMR lipidomics in embryonic zebrafish

  2021cites this paper
• Genetic therapy for congenital myopathies

  2021cites this paper
• Hepatobiliary disease in XLMTM: a common comorbidity with potential impact on treatment strategies

  2021cites this paper
• Natural history of a mouse model of X-linked myotubular myopathy

  2021cites this paper
• Common Pathogenic Mechanisms in Centronuclear and Myotubular Myopathies and Latest Treatment Advances

  2021influential citation
• Activation Mechanisms of the VPS34 Complexes

  2021cites this paper
• A novel zebrafish model of SPEG-related centronuclear myopathy (CNM): characterization and comparison with other CNM model zebrafish

  2021cites this paper
• De novo phosphoinositide synthesis in zebrafish is required for triad formation but not essential for myogenesis

  2020cites this paper
• Zebrafish Models of LAMA2-Related Congenital Muscular Dystrophy (MDC1A)

  2020cites this paper
• The intragenic microRNA miR199A1 in the dynamin 2 gene contributes to the pathology of X-linked centronuclear myopathy

  2020cites this paper
• Novel roles of phosphoinositides in signaling, lipid transport, and disease.

  2020cites this paper
• From Mice to Humans: An Overview of the Potentials and Limitations of Current Transgenic Mouse Models of Major Muscular Dystrophies and Congenital Myopathies

  2020cites this paper
• The Phenotype and Genotype of Congenital Myopathies Based on a Large Pediatric Cohort.

  2020cites this paper
• Identification of drug modifiers for RYR1-related myopathy using a multi-species discovery pipeline

  2020cites this paper
• Whole-genome analysis of noncoding genetic variations identifies multiscale regulatory element perturbations associated with Hirschsprung disease

  2020cites this paper
• X-linked myotubular myopathy

  2019cites this paper
• Failure to identify modifiers of NEBULIN-related nemaline myopathy in two pre-clinical models of the disease

  2019cites this paper
• Mortality and respiratory support in X-linked myotubular myopathy: a RECENSUS retrospective analysis

  2019cites this paper
• Identification of drug modifiers for RYR1 related myopathy using a multi-species discovery pipeline

  2019cites this paper
• Therapeutic Aspects in Congenital Myopathies.

  2019cites this paper
• Elucidating Effects of RYR1 in a Zebrafish Model and a Novel Recessive Mouse Model

  2019cites this paper
• Investigating the Functional Consequence of Pik3c2b Ablation in a Skeletal Muscle Model

  2019cites this paper
• Phosphoinositides in autophagy: current roles and future insights

  2019cites this paper
• The expanding spectrum of neurological disorders of phosphoinositide metabolism

  2019influential citation
• Detection of multiple sclerosis using blood and brain cells transcript profiles: Insights from comprehensive bioinformatics approach

  2019cites this paper
• Mouse model of severe recessive RYR1-related myopathy.

  2019cites this paper
• PI3K isoforms in cell signalling and vesicle trafficking

  2019cites this paper
• Class II PI3K Functions in Cell Biology and Disease.

  2019cites this paper
• PI 3 ‐ kinase isoforms at the crossroads of signalling and vesicular traffic

  2019cites this paper
• Insights into wild type dynamin 2 and the consequences of DNM2 mutations from transgenic zebrafish.

  2019cites this paper
• Period of doctorate studies : January 2015 to August 2019

  2019cites this paper
• Gene Therapy for X-Linked Myotubular Myopathy

  2019cites this paper
• Ca2+-induced sarcoplasmic reticulum Ca2+ release in myotubularin-deficient muscle fibers.

  2019cites this paper
• Tamoxifen prolongs survival and alleviates symptoms in mice with fatal X-linked myotubular myopathy

  2018cites this paper
• Intravenous Administration of a MTMR2-Encoding AAV Vector Ameliorates the Phenotype of Myotubular Myopathy in Mice

  2018cites this paper
• In vivo imaging of emerging endocrine cells reveals a requirement for PI3K-regulated motility in pancreatic islet morphogenesis

  2018cites this paper
• Congenital myopathies: disorders of excitation–contraction coupling and muscle contraction

  2018cites this paper
• The genetics of congenital myopathies.

  2018cites this paper
• Centronuclear myopathy: advances in genetic understanding and potential for future treatments

  2018cites this paper
• Advances in the Understanding of Skeletal Myopathies from Zebrafish Models

  2018cites this paper
• Gene therapy strategies for X-linked myotubular myopathy

  2018cites this paper
• Recent advances in understanding congenital myopathies

  2018cites this paper
• Tamoxifen therapy in a murine model of myotubular myopathy

  2018cites this paper
• An In Vitro Model of Charcot-Marie-Tooth Disease Type 4B2 Provides Insight Into the Roles of MTMR13 and MTMR2 in Schwann Cell Myelination

  2018cites this paper
• Centronuclear myopathies under attack: A plethora of therapeutic targets

  2018influential citation
• Single Intramuscular Injection of AAV-shRNA Reduces DNM2 and Prevents Myotubular Myopathy in Mice.

  2018cites this paper
• Affected female carriers of MTM1 mutations display a wide spectrum of clinical and pathological involvement: delineating diagnostic clues

  2017cites this paper
• Phosphoinositides, Major Actors in Membrane Trafficking and Lipid Signaling Pathways

  2017cites this paper
• Phosphatidlyinositol-3-kinase C2 beta (PI3KC2β) is a potential new target to treat IgE mediated disease

  2017cites this paper
• Expression of the neuropathy-associated MTMR2 gene rescues MTM1-associated myopathy

  2017cites this paper
• Treating pediatric neuromuscular disorders: The future is now

  2017cites this paper
• A natural history study of X-linked myotubular myopathy

  2017cites this paper
• A multicenter, retrospective medical record review of X‐linked myotubular myopathy: The recensus study

  2017cites this paper
• WANTED - Dead or alive: Myotubularins, a large disease-associated protein family.

  2017cites this paper
• Phosphoinositide conversion in endocytosis and the endolysosomal system

  2017cites this paper
• Characterization of a Zebrafish Model of X-linked Centronuclear Myopathy for Therapeutic Drug Development

  2017cites this paper
• Muscle cell communication in development and repair

  2017cites this paper
• Phosphatidylinositol 3-kinase inhibition restores Ca2+ release defects and prolongs survival in myotubularin-deficient mice

  2016cites this paper
• Product Data Sheet Chemical Properties Product

  2016cites this paper
• Bright light-harvesting nanoantenna with hydrophobic ion pairs

  year unknowncites this paper